Venture capital Archives

News and Trends 4 Jan 2018

Boehringer Ingelheim Doubles its Venture Fund for Exciting Biotech

Boehringer Ingelheim has committed to continue helping young companies grow by doubling the size of its venture fund to €250M, which will allow it to expand its focus. Boehringer Ingelheim is a big pharma hoping to drive the development of new and effective medicines. Today, the company announced that it has more than doubled the size of […]

January 4, 2018 - 2 minutesmins - By Alex Dale

Best in Biotech 28 Dec 2017

Bored Between the Holidays? Watch these Biotech Videos!

Christmas might have passed, but we have more videos for you to watch on a dreary winter day! Here are our highlights from 2017. It’s vacation time! If you’ve worn out the holiday movies, catch up on our biotech ones. It was a busy year, and we produced a lot, thanks to our new Hangouts […]

December 28, 2017 - 4 minutesmins - By Evelyn Warner

News and Trends 20 Dec 2017

Christmas Has Come Early for Nordic Biotechs as a Norwegian Fund Readies €100M Injection

Hadean Ventures has closed its first fund, which it will begin to invest in life sciences companies around Europe, particularly in the Nordic region. Hadean Ventures is a VC fund based in Oslo, Norway, with the aim of improving healthcare to help patients that are suffering around the world. The VC has closed Hadean Capital […]

December 20, 2017 - 2 minutesmins - By Alex Dale

News and Trends 12 Dec 2017

The Largest Medtech Fund in Europe is Here Thanks to This Dutch VC

LSP has closed a €280M fund, Health Economics Fund 2, that is dedicated to medtech with a focus on containing costs while delivering effective healthcare. There’s a new medtech fund in town, Health Economics Fund 2 (HEF 2), and it’s the largest in Europe. Managed by Partners Anne Portwich, Rudy Dekeyser, Fouad Azzam, Clemens van Blitterswiik, […]

December 12, 2017 - 2 minutesmins - By Evelyn Warner

Interview 20 Nov 2017

Thinking of Leaving Academia? Read this VC Partner’s Story

Anne Portwich, Partner at venture capital firm LSP, told me about her career path and how to succeed in the life science industry. Anne Portwich became the first woman partner at LSP in 2011. The fund has raised more than $1B since it was founded more than 25 years ago, and the cash goes mainly to […]

November 20, 2017 - 9 minutesmins - By Evelyn Warner

Hubert Birner TVM Capital Bio Europe 2017

Interview 13 Nov 2017

Where is the Money Going in Biotech? A Peek into European VC Strategy

Hubert Birner, Managing Partner at TVM Capital Life Science, discusses his strategy to adapt to the European funding constraints and the areas with most potential for biotech investment. TVM Capital Life Science is a venture capital firm focusing on biotech, pharma and medtech. With over €900M under management and offices in both Munich and Montreal, TVM […]

November 13, 2017 - 3 minutesmins - By Clara Rodríguez Fernández

Interview 8 Nov 2017

Interviewing Europe’s Most Intense Investor about Trends in Biotech

I interviewed Kate Bingham of SV Health Investors about Alzheimer’s, checkpoint inhibitors, gender diversity and more at BIO Europe. BIO Europe 2017 was off to a racing start on Monday morning when I chatted with Kate Bingham, Managing Partner of SV Health Investors, formerly SV Life Sciences. Since she joined the firm in 1991, she […]

November 8, 2017 - 6 minutesmins - By Evelyn Warner

Interview 2 Nov 2017

Meet the Top Biotech Investor Who Picked His Career By Accident

Kevin Johnson, Partner at Medicxi, joined us last week for our Meetup in London. He told us how he ended as an investor despite starting in biotech. Fresh from his PhD at Cambridge, Johnson stepped into biotech and led the development of a number of human antibodies at Cambridge Antibody Technology (CAT). The company was eventually responsible for […]

November 2, 2017 - 4 minutesmins - By Alex Dale

biogeneration ventures medical biotech fund

News and Trends 1 Nov 2017

Update: Dutch VC Raises €82M for a New European Medical Biotech Fund

Update (1/11/2017): BioGeneration Ventures has surpassed its third round goal of raising €75M by securing €82M. The VC has received extra support from Bristol-Myers Squibb and Johnson & Johnson Innovation. Originally published 27/06/2017 BioGeneration Ventures has secured €66M from Dutch and EU investors that will go towards biotechs developing therapeutics, diagnostics and medical devices. BioGeneration Ventures is a Dutch VC that focuses its investments on […]

November 1, 2017 - 2 minutesmins - By Clara Rodríguez Fernández

In Depth 24 Oct 2017

Where to Find the Money to Get Your Biotech Startup Up with the Big Boys

What do you need to kickstart your own biotech company? A great idea, of course. Industry knowledge, a plus. Money… This could be tricky. Breaking into the biotech industry is one of the most expensive decisions that you can make. First, you need ground-breaking science that has what it takes to change its respective field, […]

October 24, 2017 - 8 minutesmins - By Alex Dale

Interview 16 Oct 2017

Meet the Former Banker at the Helm of Denmark’s Healthcare Giant, Novo Holdings

Kasim Kutay has ridden the biotech investment wave. First, he helped build Morgan Stanley’s European healthcare group, then did the same at Moelis & Co and now he heads Novo Holdings, the majority shareholder of Danish household biotech names NovoZymes and Novo Nordisk. I asked him about the company’s healthcare investment strategy and his CEO […]

October 16, 2017 - 7 minutesmins - By Evelyn Warner

Interview 27 Sep 2017

What’s this Top Swiss VC Up To These Days? General Partner Tells All

Philip caught up with Markus Hosang to find out which companies the VC is keeping an eye on after its next round of fundraising. General Partner, Markus Hosang has a strong background in pharma and VC, which serves him well when searching through the bustling biotech industry in Europe. BioMed Partners is a very active […]

September 27, 2017 - 3 minutesmins - By Alex Dale

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Venture capital

Boehringer Ingelheim Doubles its Venture Fund for Exciting Biotech

Bored Between the Holidays? Watch these Biotech Videos!

Christmas Has Come Early for Nordic Biotechs as a Norwegian Fund Readies €100M Injection

The Largest Medtech Fund in Europe is Here Thanks to This Dutch VC

Thinking of Leaving Academia? Read this VC Partner’s Story

Where is the Money Going in Biotech? A Peek into European VC Strategy

Interviewing Europe’s Most Intense Investor about Trends in Biotech

Meet the Top Biotech Investor Who Picked His Career By Accident

Update: Dutch VC Raises €82M for a New European Medical Biotech Fund

Where to Find the Money to Get Your Biotech Startup Up with the Big Boys

Meet the Former Banker at the Helm of Denmark’s Healthcare Giant, Novo Holdings

What’s this Top Swiss VC Up To These Days? General Partner Tells All

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!